Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine

NCT01118273 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep

Interventions

DRUG: Naproxen Sodium 440 mg (BAYH6689) / DPH 50mg
DRUG: Naproxen Sodium 440 mg (BAYH6689)
DRUG: Naproxen Sodium 220 mg (BAYH6689) / DPH 50mg
DRUG: Naproxen Sodium 220 mg (BAYH6689)
DRUG: DPH 50mg
DRUG: Ibuprofen 400 mg / Diphenhydramine citrate 76 mg

Sponsor

Bayer